Survival of Adults With Systemic Sclerosis Following Lung Transplantation: A Nationwide Cohort Study

Abstract

A diagnosis of SSc may confer an increased risk of death 1 year following lung transplantation compared to a diagnosis of ILD, but this risk is similar to that of PAH, a widely accepted indication for lung transplantation. Future work should identify modifiable risk factors that can improve transplant outcomes in this population.